DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Finerenone is an investigational drug.
There have been 11 clinical trials for Finerenone. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2015.
The most common disease conditions in clinical trials are Kidney Diseases, Diabetes Mellitus, Type 2, and Diabetes Mellitus. The leading clinical trial sponsors are Bayer and [disabled in preview].
There are thirty-one US patents protecting this investigational drug and four hundred and eighty-nine international patents.
Recent Clinical Trials for Finerenone
|A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy, DR)||Bayer||N/A|
|Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) and Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood||Bayer||Phase 3|
|Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Volunteers||Bayer||Phase 1|
Top disease conditions for Finerenone
Top clinical trial sponsors for Finerenone
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Finerenone||⤷ Free Forever Trial||Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro- 1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient||BAYER PHARMA AG (Berlin, DE)||⤷ Free Forever Trial|
|Finerenone||⤷ Free Forever Trial||Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof||BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE)||⤷ Free Forever Trial|
|Finerenone||⤷ Free Forever Trial||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||⤷ Free Forever Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Finerenone||Argentina||AR101403||2034-08-01||⤷ Free Forever Trial|
|Finerenone||Australia||AU2015295376||2034-08-01||⤷ Free Forever Trial|
|Finerenone||Brazil||BR112017001678||2034-08-01||⤷ Free Forever Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|